2 January, 2026 Efficacy of anakinra in reducing progression to organ dysfunction in patients with pneumonia (INSPIRE): a randomised, double-blind, placebo-controlled phase IIa trial 2026-10-14T11:53:05+03:00By hiss|Categories: Biomarkers, Publications, Therapeutics|Tags: Anakinra, mortality, pneumonia, presepsin| The Lancet Regional Health - Europe 2026 Read More
